199 related articles for article (PubMed ID: 32820987)
21. Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia.
Harapan H; Wagner AL; Yufika A; Setiawan AM; Anwar S; Wahyuni S; Asrizal FW; Sufri MR; Putra RP; Wijayanti NP; Salwiyadi S; Maulana R; Khusna A; Nusrina I; Shidiq M; Fitriani D; Muharrir M; Husna CA; Yusri F; Maulana R; Rajamoorthy Y; Groneberg DA; Müller R; Mudatsir M
Vaccine; 2020 Oct; 38(43):6800-6806. PubMed ID: 32861468
[TBL] [Abstract][Full Text] [Related]
22. Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia.
Harapan H; Mudatsir M; Yufika A; Nawawi Y; Wahyuniati N; Anwar S; Yusri F; Haryanti N; Wijayanti NP; Rizal R; Fitriani D; Maulida NF; Syahriza M; Ikram I; Fandoko TP; Syahadah M; Asrizal FW; Aletta A; Jamil KF; Rajamoorthy Y; Hadisoemarto PF; Wagner AL; Groneberg DA; Kuch U; Sasmono RT; Müller R; Imrie A
Vaccine; 2019 Mar; 37(11):1398-1406. PubMed ID: 30739794
[TBL] [Abstract][Full Text] [Related]
23. Does improved risk information increase the value of cholera prevention? An analysis of stated vaccine demand in slum areas of urban Bangladesh.
Aziz S; Pakhtigian EL; Akanda AS; Jutla A; Huq A; Alam M; Ashan GU; Colwell RR
Soc Sci Med; 2021 Mar; 272():113716. PubMed ID: 33571944
[TBL] [Abstract][Full Text] [Related]
24. Willingness-to-Accept and Willingness-to-Pay Ratios of Prevention of Mother-to-Child Transmission Services in a Nigerian Hospital: A Cross-Sectional Contingent Valuation Study.
Isah A; Adibe MO; Anosike C; Aluh DO; Onyekwelu PO; Okonta MJ; Ukwe CV
Value Health Reg Issues; 2019 Sep; 19():112-121. PubMed ID: 31404819
[TBL] [Abstract][Full Text] [Related]
25. Community acceptance and willingness to pay for hypothetical COVID-19 vaccines in a developing country: a web-based nationwide study in Nigeria.
Okafor UG; Isah A; Onuh JC; Mgbemena CB; Ubaka CM
Pan Afr Med J; 2021; 40():112. PubMed ID: 34887986
[TBL] [Abstract][Full Text] [Related]
26. Mothers' willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study.
Umeh IB; Nduka SO; Ekwunife OI
Cost Eff Resour Alloc; 2016; 14():8. PubMed ID: 27274335
[TBL] [Abstract][Full Text] [Related]
27. Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia.
Harapan H; Sallam M; Fathima R; Kusuma HI; Anwar S; Nalapraya WY; Wibowo A; Kumara Wati KD; Medina A; Defrita AH; Astri Y; Prasetyowati A; Nurfarahin N; Khusna A; Oktariana S; Anwar S; Yussar MO; Khotimah S; Maria Nainggolan BW; Amalia Badri PR; Argarini R; Winardi W; Sharun K; Indah R; Rajamoorthy Y; Wagner AL; Mudatsir M
Infect Dis Rep; 2022 Dec; 14(6):1017-1032. PubMed ID: 36547247
[TBL] [Abstract][Full Text] [Related]
28. Willingness to pay for a 4% chlorhexidine (7.1% chlorhexidine digluconate) product for umbilical cord care in rural Bangladesh: a contingency valuation study.
Coffey PS; Metzler M; Islam Z; Koehlmoos TP
BMC Int Health Hum Rights; 2013 Oct; 13():44. PubMed ID: 24139384
[TBL] [Abstract][Full Text] [Related]
29. Parents' willingness to pay for a COVID-19 vaccine for themselves and their children in the United States.
Catma S; Reindl D
Hum Vaccin Immunother; 2021 Sep; 17(9):2919-2925. PubMed ID: 33929290
[TBL] [Abstract][Full Text] [Related]
30. Willingness to Pay for a Hypothetical COVID-19 Vaccine in the United States: A Contingent Valuation Approach.
Catma S; Varol S
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33915680
[TBL] [Abstract][Full Text] [Related]
31. On willingness to pay for Covid-19 vaccines: a case study from India.
Das U; Rathore U; Pal R
Hum Vaccin Immunother; 2021 Dec; 17(12):4904-4913. PubMed ID: 34757868
[TBL] [Abstract][Full Text] [Related]
32. The demand for a COVID-19 vaccine in Kenya.
Carpio CE; Sarasty O; Hudson D; Macharia A; Shibia M
Hum Vaccin Immunother; 2021 Oct; 17(10):3463-3471. PubMed ID: 34242114
[TBL] [Abstract][Full Text] [Related]
33. Willingness to Pay for a Coronavirus Vaccine and Its Associated Determinants in Lebanon.
Karam MM; Baki JA; Al-Hajje A; Sraj M; Awada S; Salameh P; Ajrouche R
Value Health Reg Issues; 2022 Jul; 30():18-25. PubMed ID: 35033800
[TBL] [Abstract][Full Text] [Related]
34. Acceptability of hypothetical dengue vaccines among travelers.
Benoit CM; MacLeod WB; Hamer DH; Sanchez-Vegas C; Chen LH; Wilson ME; Karchmer AW; Yanni E; Hochberg NS; Ooi WW; Kogelman L; Barnett ED
J Travel Med; 2013; 20(6):346-51. PubMed ID: 24165380
[TBL] [Abstract][Full Text] [Related]
35. Acceptability and Willingness-to-Pay for a Hypothetical Ebola Virus Vaccine in Nigeria.
Ughasoro MD; Esangbedo DO; Tagbo BN; Mejeha IC
PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003838. PubMed ID: 26076007
[TBL] [Abstract][Full Text] [Related]
36. Determinants of willingness to pay for self-paid vaccines in China.
Hou Z; Jie Chang ; Yue D; Fang H; Meng Q; Zhang Y
Vaccine; 2014 Jul; 32(35):4471-4477. PubMed ID: 24968160
[TBL] [Abstract][Full Text] [Related]
37. The demand for a COVID-19 vaccine in Ecuador.
Sarasty O; Carpio CE; Hudson D; Guerrero-Ochoa PA; Borja I
Vaccine; 2020 Dec; 38(51):8090-8098. PubMed ID: 33187765
[TBL] [Abstract][Full Text] [Related]
38. Health-care Workers' Willingness to Pay for COVID-19 Vaccines in Eastern Ethiopia: Using Contingent Valuation Method.
Merga BT; Ayana GM; Negash B; Alemu A; Abdurke M; Abdu A; Balis B; Bekana M; Fekadu G; Raru TB
Clinicoecon Outcomes Res; 2022; 14():395-404. PubMed ID: 35615661
[TBL] [Abstract][Full Text] [Related]
39. Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: A cross-sectional study in Aceh.
Mudatsir M; Anwar S; Fajar JK; Yufika A; Ferdian MN; Salwiyadi S; Imanda AS; Azhars R; Ilham D; Timur AU; Sahputri J; Yordani R; Pramana S; Rajamoorthy Y; Wagner AL; Jamil KF; Harapan H
F1000Res; 2019; 8():1441. PubMed ID: 32399182
[No Abstract] [Full Text] [Related]
40. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
